Literature DB >> 9325078

Decreased expression of cytokines that induce type 1 helper T cell/interferon-gamma responses in genetically susceptible mice infected with Mycobacterium avium.

K Kobayashi1, N Nakata, M Kai, T Kasama, Y Hanyuda, Y Hatano.   

Abstract

Mycobacterium avium is an intracellular microorganism that infects and multiplies within macrophages. Cell-mediated immunity plays an important role in host defense. Two cytokines, interleukin 12 (IL-12) and interferon-gamma-inducing factor (IGIF), produced mainly by macrophages, are critical for the development of type 1 helper T (Th1) cell/interferon-gamma (IFN-gamma) responses and cell-mediated immunity. In this report, by using a mouse model of disseminated M. avium infection, we demonstrate that genetically susceptible BALB/c mice show decreased expression of IL-12 and IGIF in association with a diminished IFN-gamma/Th1 response. Conversely, resistant DBA/2 mice exhibited increased expression of IL-12, IGIF, and IFN-gamma. In both strains of infected mice, the level of IL-4/Th2 response was similar. These results suggest that decreased expression of IL-12 and IGIF leads to a diminished Th1 response without reciprocal enhanced Th2 responses in susceptible mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325078     DOI: 10.1006/clin.1997.4421

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  13 in total

Review 1.  How diverse--CD4 effector T cells and their functions.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  J Mol Cell Biol       Date:  2009-05-28       Impact factor: 6.216

2.  Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.

Authors:  Kathleen R Page; Anne E Jedlicka; Benjamin Fakheri; Gregory S Noland; Anup K Kesavan; Alan L Scott; Nirbhay Kumar; Yukari C Manabe
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Trehalose 6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice.

Authors:  H Yamagami; T Matsumoto; N Fujiwara; T Arakawa; K Kaneda; I Yano; K Kobayashi
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 4.  Regulatory T cells: immune suppression and beyond.

Authors:  Yisong Y Wan
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

5.  Expression of IL-18 by Mycobacterium avium-infected human monocytes; association with M. avium virulence.

Authors:  H Shiratsuchi; J J Ellner
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

6.  Interleukin-12-secreting fibroblasts are more efficient than free recombinant interleukin-12 in inducing the persistent resistance to Mycobacterium avium complex infection.

Authors:  B Y Kang; S W Chung; Y S Lim; E J Kim; S H Kim; S Y Hwang; T S Kim
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

7.  Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation.

Authors:  Mahmoud Rouabhia; Geneviève Ross; Nathalie Pagé; Jamila Chakir
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

8.  Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.

Authors:  Y Luo; H Yamada; X Chen; A A Ryan; D P Evanoff; J A Triccas; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

9.  Dietary soy phytoestrogens and ERalpha signalling modulate interferon gamma production in response to bacterial infection.

Authors:  E M Curran; B M Judy; L G Newton; D B Lubahn; G E Rottinghaus; R S Macdonald; C Franklin; D M Estes
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

10.  NK cells modulate the cytotoxic activity generated by Mycobacterium leprae-hsp65 in leprosy patients: role of IL-18 and IL-13.

Authors:  S de la Barrera; M Finiasz; S Fink; J Ilarregui; M Aleman; L Olivares; M C Franco; G Pizzariello; M del Carmen Sasiain
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.